The human genome and the gut microbiome: molecular mechanisms of interaction in the context of the holobiont concept

Authors

DOI:

https://doi.org/10.14739/2310-1237.2026.1.350351

Keywords:

microbiome, genomics, holobiont, immunity, metabolism, gene polymorphism, GWAS

Abstract

Over the last decade, scientific understanding of the human body has shifted from an anthropocentric model to the concept of the holobiont – an integrated ecological unit consisting of the host and its microbiome. The interaction between the human genome and microbiota is a key determinant of physiology, metabolism, and disease susceptibility, yet the mechanisms of this genetic control remain insufficiently systematized.

Aim. To analyze current data on the influence of the host genome on the formation and control of gut microbiota composition and function, and to identify key genetic loci and molecular mechanisms of interaction within the “genome – microbiome” system.

Materials and methods. A review of scientific literature was conducted using PubMed, Scopus, and Web of Science databases. Results from genome-wide association studies (GWAS), twin studies, and molecular genetic research were analyzed.

Results. Host genetics represents a significant factor in shaping the microbial profile, with heritability estimates for specific taxa ranging 5–45 %. Two main mechanisms of genetic control are identified: immune sculpting (genes NOD2, IL23R) and metabolic gardening (genes LCT, FUT2, APOA5). Synergistic effects of defects in these systems significantly increase the risk of chronic inflammatory and metabolic diseases. The hologenome concept, which views the combined genome of the host and microbiome as a single unit of evolution, is described.

Conclusions. The host genome actively shapes the microbial ecosystem through immunological and metabolic mechanisms. Understanding these interactions paves the way for personalized medicine based on a hologenomic approach, particularly for developing individualized microbiome correction strategies.

Author Biographies

O. O. Kremzer, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor of the Department of Clinical Pharmacology, Pharmacy, Pharmacotherapy and Cosmetology

O. V. Kraidashenko, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor, Head of the Department of Clinical Pharmacology, Pharmacy, Pharmacotherapy and Cosmetology

O. O. Kraidashenko, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, Assistant at the Department of Internal Medicine 3

References

  1. Qadri QR, Lai X, Zhao W, Zhang Z, Zhao Q, Ma P, et al. Exploring the Interplay between the Hologenome and Complex Traits in Bovine and Porcine Animals Using Genome-Wide Association Analysis. Int J Mol Sci. 2024;25(11):6234. doi: https://doi.org/10.3390/ijms25116234
    | |
  2. Lee J-Y, Bays DJ, Savage HP, Bäumler AJ. The human gut microbiome in health and disease: time for a new chapter? Infect Immun. 2024;92(11):e0030224. doi: https://doi.org/10.1128/iai.00302-24
    | |
  3. Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016;375(24):2369-79. doi: https://doi.org/10.1056/NEJMra1600266
    | |
  4. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8):e1002533. doi: https://doi.org/10.1371/journal.pbio.1002533
    | |
  5. Almeida A, Nayfach S, Boland M, Strozzi F, Beracochea M, Shi ZJ, et al. A unified catalog of 204,938 reference genomes from the human gut microbiome. Nat Biotechnol. 2021;39(1):105-14. doi: https://doi.org/10.1038/s41587-020-0603-3
    | |
  6. Rolland A, Douard V, Lapaque N. Role of pattern recognition receptors and microbiota-derived ligands in obesity. Front Microbiomes. 2024;3:1324476. doi: https://doi.org/10.3389/frmbi.2024.1324476
    | |
  7. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805-20. doi: https://doi.org/10.1016/j.cell.2010.01.022
    | |
  8. Johansson ME, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol. 2016;16(10):639-49. doi: https://doi.org/10.1038/nri.2016.88
    | |
  9. Li Z, Shang D. NOD1 and NOD2: Essential Monitoring Partners in the Innate Immune System. Curr Issues Mol Biol. 2024;46(9):9463-79. doi: https://doi.org/10.3390/cimb46090561
    | |
  10. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165(6):1332-45. doi: https://doi.org/10.1016/j.cell.2016.05.041
    | |
  11. Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53(2):156-65. doi: https://doi.org/10.1038/s41588-020-00763-1
    | |
  12. Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210-5. doi: https://doi.org/10.1038/nature25973
    | |
  13. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human genetics shape the gut microbiome. Cell. 2014;159(4):789-99. doi: https://doi.org/10.1016/j.cell.2014.09.053
    | |
  14. Waters JL, Ley RE. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biol. 2019;17(1):83. doi: https://doi.org/10.1186/s12915-019-0699-4
    | |
  15. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut microbiome variation. Science. 2016;352(6285):560-4. doi: https://doi.org/10.1126/science.aad3503
    | |
  16. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439. doi: https://doi.org/10.1126/science.1237439
    | |
  17. Masaki S, Masuta Y, Honjo H, Kudo M, Watanabe T. NOD2-mediated dual negative regulation of inflammatory responses triggered by TLRs in the gastrointestinal tract. Front Immunol. 2024;15:1433620. doi: https://doi.org/10.3389/fimmu.2024.1433620
    | |
  18. Lauro ML, Burch JM, Grimes CL. The effect of NOD2 on the microbiota in Crohn's disease. Curr Opin Biotechnol. 2016;40:97-102. doi: https://doi.org/10.1016/j.copbio.2016.02.028
    | |
  19. Neurath MF. IL-23: a master switch in inflammatory bowel diseases. Cytokine Growth Factor Rev. 2019;45:1-8. doi: https://doi.org/10.1016/j.cytogfr.2018.12.002
    | |
  20. Kumar P, Monin L, Castillo P, Elsegeiny W, Horne W, Eddens T, et al. Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. Immunity. 2016;44(3):659-71. doi: https://doi.org/10.1016/j.immuni.2016.02.007
    | |
  21. Krueger JG, Eyerich K, Kuchroo VK, Ritchlin CT, Abreu MT, Elloso MM, et al. IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy. Front Immunol. 2024;15:1331217. doi: https://doi.org/10.3389/fimmu.2024.1331217
    | |
  22. Ségurel L, Bon C. On the Evolution of Lactase Persistence in Humans. Annu Rev Genomics Hum Genet. 2017;18:297-319. doi: https://doi.org/10.1146/annurev-genom-091416-035340
    | |
  23. Luo K, Chen GC, Zhang Y, Moon JY, Xing J, Peters BA, et al. Variant of the lactase LCT gene explains association between milk intake and incident type 2 diabetes. Nat Metab. 2024;6(1):169-86. doi: https://doi.org/10.1038/s42255-023-00961-1
    | |
  24. Pickard JM, Maurice CF, Kinnebrew MA, Abt MC, Schenten D, Golovkina TV, et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature. 2014;514(7524):638-41. doi: https://doi.org/10.1038/nature13823
    | |
  25. Ferrer-Admetlla A, Bosch E, Sikora M, Marquès-Bonet T, Ramírez-Soriano A, Muntasell A, et al. Balancing selection is the main force shaping the evolution of innate immunity genes. J Immunol. 2008;181(2):1315-22. doi: https://doi.org/10.4049/jimmunol.181.2.1315
    | |
  26. Thorman AW, Adkins G, Conrey SC, Burrell AR, Yu Y, White B, et al. Gut Microbiome Composition and Metabolic Capacity Differ by FUT2 Secretor Status in Exclusively Breastfed Infants. Nutrients. 2023;15(2):471. doi: https://doi.org/10.3390/nu15020471
    | |
  27. Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism. 2010;59(7):993-9. doi: https://doi.org/10.1016/j.metabol.2009.10.022
    | |
  28. Xu C, Gu L, Hu L, Jiang C, Li Q, Sun L, et al. FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer. Nat Commun. 2023;14(1):2042. doi: https://doi.org/10.1038/s41467-023-37590-x
    | |
  29. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294(5540):169-73. doi: https://doi.org/10.1126/science.1064852
    | |
  30. Vojinovic D, Radjabzadeh D, Kurilshikov A, Amin N, Wijmenga C, Franke L, et al. Relationship between gut microbiota and circulating metabolites in population-based cohorts. Nat Commun. 2019;10(1):5813. doi: https://doi.org/10.1038/s41467-019-13721-1
    | |
  31. Boulund U, Bastos DM, Ferwerda B, van den Born BJ, Pinto-Sietsma SJ, Galenkamp H, et al. Gut microbiome associations with host genotype vary across ethnicities and potentially influence cardiometabolic traits. Cell Host Microbe. 2022;30(10):1464-80.e6. doi: https://doi.org/10.1016/j.chom.2022.08.013
    | |
  32. Duelo A, Sánchez-Pérez S, Pellicer-Roca S, Sánchez-Buxens S, Comas-Basté O, Latorre-Moratalla ML, et al. Improvement of Histamine Intolerance Symptoms in Pregnant Women with Diamine Oxidase Deficiency: An Exploratory Study. J Clin Med. 2025;14(13):4573. doi: https://doi.org/10.3390/jcm14134573
    | |

Downloads

Additional Files

Published

2026-04-30

How to Cite

1.
Kremzer OO, Kraidashenko OV, Kraidashenko OO. The human genome and the gut microbiome: molecular mechanisms of interaction in the context of the holobiont concept. Pathologia [Internet]. 2026Apr.30 [cited 2026May16];23(1):56-61. Available from: https://pat.zsmu.edu.ua/article/view/350351

Issue

Vol. 23 No. 1 (2026)

Section

Review

License

Copyright (c) 2026 O. O. Kremzer, O. V. Kraidashenko, O. O. Kraidashenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Лицензия Creative Commons